Semi-Annual Consolidated Statement Of Comprehensive Income

KISSEI PHARMACEUTICAL CO.,LTD. - Filing #7252445

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
11,538,000,000 JPY
11,538,000,000 JPY
11,538,000,000 JPY
11,975,000,000 JPY
11,538,000,000 JPY
10,307,000,000 JPY
11,289,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
10,307,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-14,031,000,000 JPY
22,398,000,000 JPY
Remeasurements of defined benefit plans, net of tax
141,000,000 JPY
2,357,000,000 JPY
Other comprehensive income
-13,890,000,000 JPY
24,755,000,000 JPY
Comprehensive income
-1,914,000,000 JPY
36,044,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,928,000,000 JPY
35,851,000,000 JPY
Comprehensive income attributable to non-controlling interests
14,000,000 JPY
192,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.